Neuroleptic malignant syndrome induced by metoclopramide.

  title={Neuroleptic malignant syndrome induced by metoclopramide.},
  author={Anne Donnet and Jean Robert Harl{\'e} and Juan C. Dumont and A Alif Cherif},
  journal={Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie},
  volume={45 10},
Neuroleptic malignant syndrome (NMS) associated with metoclopramide is rare. NMS probably results from neuroleptic-induced dopamine receptor blockade. We describe a case and have found only seven reports of metoclopramide-induced NMS in the literature.